logo-loader
viewAustralis Capital Inc

Australis Capital to merge with Folium Biosciences in 'transformational deal'

Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) CEO Scott Dowty caught up with Proactive's Andrew Scott while in London to discuss the news that they're to merge with Folium Biosciences.

Under the merger plan Folium will become a wholly owned subsidiary of Australis -- which will be rebranded as Folium Biosciences and will carry on the current business of Folium. 

Quick facts: Australis Capital Inc

Price: 0.17 CAD

CSE:AUSA
Market: CSE
Market Cap: $28.89 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Australis Capital Inc named herein, including the promotion by the Company of Australis Capital Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australis Capital sees big opportunity with recent acquisition Green...

Australis Capital (OTCQB:AUSAF) CEO Scott Dowty updates Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in LA, California.

on 5/6/19

2 min read